These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4315949)

  • 1. [Oral vaccination against poliomyelitis using trivalent vaccines].
    Damjanowa M; Huber EG; Kraus P; Pötsch F
    Dtsch Med Wochenschr; 1970 Jun; 95(23):1265-8. PubMed ID: 4315949
    [No Abstract]   [Full Text] [Related]  

  • 2. Age for assessment of trivalent oral polio vaccination coverage: is there a need for revision in India.
    Deivanayagam N; Mala N; Nedunchelian K; Ashok TP; Ahmed SS
    Indian Pediatr; 1991 Jun; 28(6):665-8. PubMed ID: 1748517
    [No Abstract]   [Full Text] [Related]  

  • 3. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral poliomyelitis immunization. Comparison of the serological findings after two- and threefold application of a trivalent live vaccine].
    Kuwert E; Höher PG; Worringen W; Bohlmann HG; Thraenhart O
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2505-9. PubMed ID: 5484755
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent recommendations of the National Committee on Vaccines regarding polio immunization].
    Caraffa De Stefano D; Vellucci L
    Ann Ig; 2002; 14(4 Suppl 5):81-4. PubMed ID: 12389296
    [No Abstract]   [Full Text] [Related]  

  • 8. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 11. [The epidemic of paralytic poliomyelitis at Cap Bon (Tunisia) in 1971; epidemiological considerations; relative failure of vaccination].
    Beghin D; Thiry L; De Bruycker J; Ezzili M
    Brux Med; 1973 Mar; 53(3):159-68. PubMed ID: 4737258
    [No Abstract]   [Full Text] [Related]  

  • 12. [On an epidemic outbreak of poliomyelitis, type 3, in the Voivode County of Poznań in 1968].
    Walter T
    Zentralbl Bakteriol Orig; 1969; 211(2):162-6. PubMed ID: 4318358
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 14. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Combination of repeated vaccinations with oral vaccination].
    Ehrengut W; Just M; Spiess H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):111-2. PubMed ID: 1225067
    [No Abstract]   [Full Text] [Related]  

  • 16. Basis for poliomyelitis surveillance in Kabul City.
    Serý V; Thraenhart O; Zácek K; Brogger S; Omar A; Saboor A
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):311-8. PubMed ID: 4318510
    [No Abstract]   [Full Text] [Related]  

  • 17. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.